The changing trend of HIV type 1 subtypes in Nairobi

AIDS Research and Human Retroviruses

Volumn 25, Issue 3, 2009, Pages 337-342

  Lihana, Raphael W ^a   Khamadi, Samoel A ^a   Lwembe, Raphael M ^a,b   Ochleng, Washingtone ^a   Kinyua, Joyceline G ^a   Kiptoo, Michael K ^a   Muriuki, Joseph K ^a   Lagat, Nancy ^a   Osman, Saida ^a   Mwangi, Joseph M ^a   Okoth, Fredrick A ^a   Songok, Elijah M ^a,c  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b KANAZAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

POL PROTEIN; VIRUS ENVELOPE PROTEIN;

ADOLESCENT; ADULT; ARTICLE; FEMALE; GENETIC VARIABILITY; HEALTH CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; VIRUS CLASSIFICATION; VIRUS RECOMBINANT; CLASSIFICATION; CLUSTER ANALYSIS; DNA SEQUENCE; GENETIC RECOMBINATION; GENETICS; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; KENYA; MOLECULAR GENETICS; PHYLOGENY; SEQUENCE HOMOLOGY; VIROLOGY;

CLUSTER ANALYSIS; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; KENYA; MOLECULAR SEQUENCE DATA; PHYLOGENY; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY;

EID: 65449187609     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0228     Document Type: Article

References (15)

1. Thomson MM, Perez Alvarez L, and Najera R: Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2002; 2:461-471.
2. Powell RL, Zhao J, Konings FA, Tang S, Nanfack A, Burda S, Urbanski MM, Saa DR, Hewlett I, and Nyambi PN: Identification of a novel circulating recombinant form (CRF) 36-cpx in Cameroon that combines two CRFs (01-AE and 02-AG) with ancestral lineages of subtypes A and G. AIDS Res Hum Retroviruses 2007;23(8):1008-1019.
3. Dowling DE, Kim B, Mason C, et al.: Forty-one near full length HIV-1 sequences from Kenya reveals an epidemic of subtype A and A containing recombinants. AIDS 2002;16: 1809-1820.
4. Janssens W, Heyndrickx L, Fransen K, et al.: Genetic variability of HIV type 1 in Kenya. AIDS Res Hum Retroviruses 1994;10:1577-1579.
5. Heyndrickx L, Janssens W, Zekeng L, et al.: Simplified strategy for detection of recombinat human immunodeficiency virus type 1 group M isolates by gag/env heterodublex mobility assay. J Virol 2000;74:363-370.
6. Morison L, Buve A, Zekeng L, et al.: HIV-1 subtypes and the HIV epidemics in four cities in sub Saharan Africa. AIDS 2001;15(Suppl. 14):S109-S116.
7. Songok EM, Lihana RW, Kiptoo MK, et al.: Identification of env CRF10 among HIV variants circulating in rural western Kenya. AIDS Res Hum Retroviruses 2003;19(2):161-165.
8. Bikandou B, Takehisa J, Mboujeka I, et al..: Genetic subtypes of HIV type 1 in Republic of Congo. AIDS Res Hum Retroviruses 2000;16:613-619.
9. Hoelscher M, Kim B, Maboko L, et al.: High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of south west Tanzania. AIDS 2001;15:1461-1470.
10. Neilson J, Grace-John C, Carr J, et al.: Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol 1999;73:4393-4403.
11. McCutchan FE, Viputtigul K, de Sousa MS, et al.: Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand. AIDS Res Hum Retroviruses 2000;16:801-805.
12. Nyambi P, Heyndrickx L, Vereecken K, et al.: Predominance of infection with HIV-1 circulating recombinant form CRF02-AG in major Cameroonian cities and towns. AIDS 2002;16: 295-296.
13. Nkengasong JN, Janssens W, Heyndrickx L, et al.: Genotypic subtypes of HIV-1 in Cameroon. AIDS 1994;8:1405-1412.
14. Carr JK, Torimiro JN, Wolfe ND, et al.: The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon. Virology 2001;286:168-181.
15. Nijhuis M, Boucher CA, Schipper P, Leitner T, Schuurman R, and Albert J: Stochastic processes strongly influence HIV-1 evolution during suboptimal protease inhibitor therapy. Proc Natl Acad Sci USA 1998;95:14441-14446.